...
首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Influence of hemolysis, icterus and lipemia on coagulation tests as performed on Cobas t511 new analyzer
【24h】

Influence of hemolysis, icterus and lipemia on coagulation tests as performed on Cobas t511 new analyzer

机译:溶血,红细胞和脂质症对COBAS T511新分析仪进行凝血试验的影响

获取原文
获取原文并翻译 | 示例

摘要

In the coagulation laboratory, spurious hemolysis, icterus and lipemia (HIL) in test samples represent by far the leading diagnostic prenalytical challenges. The aim of this study was to assess the performance of the preanalytical module on the new hemostasis analyser Cobas Roche t511. We assessed the influence of HIL on prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fib), antithrombin and d-dimer on plasma pools aliquots with different interference degrees. Moreover, we evaluated spontaneous hemolysis by comparing results on 50 paired samples (hemolysed versus nonhemolysed). Spurious hemolysis interference studies highlight the absence of a clinical significant impact on PT, APTT and antithrombin test results at all hemoglobin concentration investigated. For Fib and d-dimer assays a clinically significant difference was observed in the most hemolysed aliquot for Fib and in the two most hemolysed aliquots for d-dimer. Spontaneous hemolysis interference studies showed no clinical significant differences for PT and antithrombin assays, instead for APTT, Fib and d-dimer we found significant statistical and clinical differences between hemolysed and non hemolysed specimens. Bilirubin interference studies and lipemic samples interference studies enable us to confirm that the differences in the results obtained between the different aliquots and reference pool is not clinically significant for all assays. HIL check preanalytical module of Cobas Roche t511 analyzer displaied excellent performance for routine use in clinical laboratories. Regardless of analytical considerations, the type of interference encountered with spurious HIL is substantially different and requires different approaches.
机译:在凝血实验室,寄生溶血,糖尿病和脂质病(HIL)在测试样品中代表着迄今为止领先的诊断产前挑战。本研究的目的是评估Preanalytical模块对新的止血分析仪COBAS ROCHE T511的性能。我们评估了HIL对凝血酶原时间(Pt),活化的部分血栓形成素时间(Aptt),纤维蛋白原(FIB),抗凝血酶和D-二聚体在不同干涉度的等分试样上的影响。此外,我们通过比较50个配对样品(溶血性与非气液)的结果进行评估的自发性溶血。杂散溶血干扰研究突出了对所有血红蛋白浓度的Pt,Aptt和抗凝血酶试验结果的缺乏缺乏临床显着影响。对于FIB和D-二聚体测定,在FIB的最溶血性等分试样中观察到临床显着差异,并且在二聚体的两种最溶血等分试样中观察到临床上差异。自发性溶血干扰研究表明,Pt和抗凝血酶分析没有临床显着差异,而是针对APTT,FIB和D-二聚体,我们发现溶血和非溶血样品之间发现了显着的统计和临床差异。胆红素干扰研究和脂肪酶样品干扰研究使我们能够确认不同的等分试样和参考池之间获得的结果的差异对于所有测定,并不临床上显着。 HIL检查COBAS ROCHE T511 Analyzer的Preanalytical模块分析仪因临床实验室的常规用途提供了良好的性能。无论分析考虑因素如何,患有杂散HIL的干扰类型基本上不同,需要不同的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号